{"credit":[{"email":"krzysimon@gmail.com","name":"Krzysztof Adam Simon","typeEntity":"Person","typeRoles":[]}],"labels":{"topic":[{"term":"Drug metabolism","uri":"http://edamontology.org/topic_3375"},{"term":"Virology","uri":"http://edamontology.org/topic_0781"},{"term":"Pharmacology","uri":"http://edamontology.org/topic_0202"},{"term":"Surgery","uri":"http://edamontology.org/topic_3421"},{"term":"Preclinical and clinical studies","uri":"http://edamontology.org/topic_3379"}]},"publication":[{"doi":"10.5114/CEH.2019.87634","pmcid":"PMC6781817","pmid":"31598558"}],"summary":{"biotoolsCURIE":"biotools:hep-druginteractions","biotoolsID":"hep-druginteractions","description":"Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C.\n\nCookies help us deliver our services. By using our services, you agree to our use of cookies. OK Learn more.\n\nAccess our free, comprehensive and user-friendly drug interaction charts.\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'OBV', 'OBV PTV', 'PTV', 'RBV'","homepage":"http://www.hep-druginteractions.org/","name":"hep-druginteractions"}}